We are very honored to receive the ”Attractive Innovation Project of 2019” award from Uppsala University Innovation for one of our sub-projects in our digital health platform AI-TRUST. The award goes out to projects that are considered likely for further progress and investments. Our software-as-a-drug platform for Parkinson´s disease have received a lot of awards and attention lately and we are looking for the lead-investor in the upcoming capitalization round.
Stardots and Uppsala university´s tremor symptom quantifier “QuEsT” was acknowledged by UUI as one of the most attractive innovation project of 2019.
Incidentally, out scientific lead Prof. Alexander Medvedev and responsible for the mathematical modelling powering our platform was recently featured in an interview as one of 24 professors from Uppsala University.
Our AI-TRUST platform is designed for the patient and significant quality of life improvements. In addition, it will reduce cost to society and provide an extremely valuable tool for the life science community and serve as a clinical trial aid.
CEO Daniel Petrini, PhD Student Fredrik Olsson and Assoc. Prof MD Dag Nyholm
CEO Daniel Petrini together with Prof. Alexander Medvedev at the award ceremony
Stardots was chosen from hundreds of companies to compete with four others in the finals in at Carnegie HQ in Stockholm. CEO Daniel Petrini got to present the company, project and team, as well as our business model, in front of a crowd of investors.
Daniel gives his seven minute pitch at Future Entrepreneur of the year 2019
We are very proud and honored to regarded as one of the best startups in Sweden and we are currently looking for investors to scale-up and bring this exciting new technology to market in order to increase quality of life for necessitous end-users: those suffering from Parkinson´s disease.
We are extremely thrilled and honored to be selected as one of five finalists in SvD/Carnegie Future entrepreneur of the year 2019. This competition puts focus on unique and sustainable business ideas with strong entrepreneurial teams. The final is due 2019-11-21 at Carnegie Hall, Stockholm Sweden.
Stardots has gained a lot of traction for our digital health platform AI-TRUST. Today’s announcement is yet one step closer to realizing our vision to increase quality of life to patients suffering from Parkinson´s disease, in addition to reduce cost to society.
CEO Daniel Petrini and COB Hanno Lindroth at the SvD/Carnegie pitch
AI-TRUST is a software-as-a-drug platform for the symptom quantification and AI-optimized treatments of Parkinson´s disease using state-of-the-art mathematical modelling. The project is a joint venture between Stardots, Uppsala University and the neurological department of Uppsala University Hospital. The management team consists of world-leading scientists, veteran programmers and successful entrepreneurs as well as international business developers in life-science.
For more information please do not hesitate to contact us.
Dag Nyholm and Alexander Medvedev from Uppsala University hospital and Uppsala University.
Stardots is thrilled to have such distinguished researchers as Prof. Alexander Medvedev and PhD Dag Nyholm onboard this digital health project designed to improve the quality of life for millions of Parkinsons patients around the world. Read more about our software-as-a-drug platform here.
Together with our friends from Harvard, MassBio and the Life Science community we recently attended the Digital Health Impact 2019 in Boston. The importance, challenges and opportunities within Digital Health were discussed. This emerging sector and platforms such as Stardots’ AI-TRUST, reflect combined advances in the Life Sciences, Digital Technology and Medical Devices industries. All bringing to light the question….How do we apply all this data to really impact outcomes and reduce costs?
Massachusetts Governor Baker addresses Digital Health Impact 2019 attendees. Sharing the significance of the inaugural event and the State’s intention to lead in this developing sector, as has been accomplished in the Biotech Industry.An insightful panel discussion at Digital Health Impact 2019 addressing themes such as, How do we apply all this data to really impact outcomes and reduce costs?
We discussed digital health and Software-as-a-Drug in general and Stardots´ platform for Parkinson’s Disease “AI-TRUST” with the attendees including the Governor of Massachusetts Charlie Baker, CBO of MassBio John Hallinan, Harvard lecturer Luba Greenwood and co-founder of Flare Capital Bill Geary. We really learned a lot from the event. The future for digital health platforms such as ours is bright.
Chris Kennedy, Stardots Business Development U.S. and Luba Greenwood, Digital Health Impact 2019 Speaker and Panel Participant, Healthcare and Tech Executive, Google Verily, Roche, Harvard Lecturer and Board Member MassBIO.
A reoccurring issue was the realization and real-world benefits of digital health platforms. We believe that such a platform should be developed in strong collaboration with the life science and health care sector. AI-TRUST is a joint venture between Stardots, Uppsala University and Uppsala University Hospital and we are working closely with neurological clinics and professionals in EU and the U.S.
Digital Health and Software-as-a-Drug (SaaD) is a new service to the health care sectorDigital Health Colleague, Luba Greenwood, opening the Digital Health Impact 2019 SymposiumChris Kennedy,Stardots Business Development U.S. and John Hallinan, Chief Business Officer, MassBio.
Stardots was invited to Umeå university in Sweden to present our company, vision and the application platform. The group focuses in neuroimaging and uses MATLAB extensively to acquire data, control outputs and for post-analysis. We were totally blown away about the quality of their research, the results they generated and the level of code they produce.
Real-time visualization of individual cells in mice involves a lot of programming to produce data-driven insights
Many programmers face the problem of commercialization and distribution of their code and solutions, and so did this group. Our application platform is built to solve these shortcomings and provide a portal for scientists and programmers to meet, exchange ideas and offer applications. We at Stardots are so honored to be collaborating with the best in the industry in order to improve the efforts of R&D and society at large.
Application engineer Kamil and scientist Tanya working on cutting edge real-time neuroimaging
Stardots attended Jefferies global health care conference in NYC to seek funding for our digital health platform for our Parkinson’s disease “AI-TRUST”. World leading health care companies presented cutting edge technologies, biotech innovations and pharmaceuticals in this investment focused conference. Stardots is currently seeking funding for our AI-TRUST platform in order to quantify symptoms and offer AI-optimized treatment to Parkinson’s in order to improve quality of life, reduce cost to society and to aid in clinical trials. It aims to provide progressive markers for Parkinson’s.
AI-TRUST is a cloud based, digital health platform and a joint-venture with Uppsala University and Uppsala University Hospital. The algorithms used for mathematical modelling are based on years of research by Prof. Alexander Medvedev and clinical trials by MD PhD Dag Nyholm.
Chris Kennedy (to the left in the photo) is our newly hired Business Development U.S and is in charge of raising funds in the Boston area.
For more information regarding investing in AI-TRUST please visit the following link: For investors
Chris Kennedy is Stardots Business Development U.S. since May 2019. He had deep involvement in the Tech and Life Science sectors, previously Co-Chair of the MassBIO Finance Committee & Forum Advisory Board Member.
Chris remains actively involved in the venture and start up community. Stardots is very pleased that Chris decided to join the team and his vision and experience will be a great asset to the company.
We won the “Game Changer” award at Venture Cup Region East finals for our application platform! The jurys motivation was:
“By making research and findings from researchers more available and cost effective, this highly competent team uses programming-skills to build bridges between science and a huge market of customers”
Stardots won the “Game Changer” award and we are now going to compete in the national finals in Gothenburg in September
Venture Cup have supported tens of thousands of entrepreneurs and helped nearly 15 000 ideas to blossom since the start in 1998. It is Sweden’s no. 1 competition and the competition where ideas become businesses. See more info here: www.venturecup.com
We are extremely honored to be competing in the nationals final in September, and besides the honor and recognition a chance to win 500 000 SEK in price money.
CEO Daniel Petrini gives a short pitch at the Venture Cup finals
Stardots has currently three products in our app store; they are all developed in MATLAB from MathWorks inc and compiled to an executable via MATLAB COMPILER.
We are very pleased to announce that Vinnova – Sweden’s innovation agency – has awarded Stardots a prestigious “Innovative Startup” grant for »QUEST« – a sub component in Stardots medical platform »EKLIPS«.
»EKLIPS« estimates symptoms and offer AI-powered treatment suggestions for patients with Parkinson’s disease (PD). The effects of PD are severe; the cost is estimated to be ~14 B€ per year in EU alone in addition to the human suffering. Around 1% of all people above 60 years will be affected by PD. »EKLIPS« will lower the cost of PD treatment for society and significantly increase quality of life for the patient.
One key component to »EKLIPS« is to estimate Parkinson’s symptoms quantitively using mathematical modelling. »QUEST« is a novel idea to estimate the associated tremor of a PD patient using the cloud, a mobile phone and advanced algorithms developed under many years by Prof. Alexander Medvedevs research group at Uppsala university. The algorithms have been tested clinically at Uppsala university Hospital (Akademiska sjukhuset) with Assoc. Prof. MD Dag Nyholm research Group and the results are impressive and encouraging. We estimate that »QUEST« will be available for Android and iOS within a year.
The red James Parkinson Tulip – a symbol for the Parkinson’s disease that is used to rise awareness and funds to R&D
»EKLIPS« is a joint venture between Stardots AB, Uppsala university and Uppsala university Hospital, and collaborates with various organizations and companies in Europe and USA. The platform is expected to be ready for launch within a few years. For more info please contact us at info@stardots.se
Stardots website uses cookies to improve your experience. AcceptRead More
